Verrica Pharmaceuticals Inc.VRCANASDAQ

Revenue (LTM)

$36M

+370.2% YoY

Net Income (LTM)

$-18M

+76.6% YoY

Free Cash Flow

$-18M

Revenue CAGR (5Y)

+31.2%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	12	9↓24.7%	5↓43.3%	8↑47.7%	36↑370.2%
Gross Profit	12	8↓27.9%	4↓47.3%	5↑10.2%	32↑565.9%
Operating Income	-31	-21↑31.1%	-66↓208.8%	-66↓0.2%	-12↑81.9%
Net Income	-35	-24↑30.2%	-67↓173.6%	-77↓14.3%	-18↑76.6%
EBITDA	-30	-22↑28.8%	-62↓188.0%	-66↓6.0%	-11↑83.1%
EPS Diluted	-12.97	-7.17↑44.7%	-14.78↓106.1%	-14.78↓0.0%	-1.68↑88.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	16	34↑117.6%	70↑102.9%	46↓33.4%	30↓34.9%
Total Current Assets	74	39↓47.4%	78↑98.2%	51↓34.0%	43↓16.9%
Total Assets	80	45↓44.2%	82↑82.5%	54↓33.7%	47↓12.9%
Total Current Liabilities	46	3↓92.5%	17↑392.2%	29↑70.4%	16↓43.3%
Total Liabilities	48	5↓90.1%	62↑1219.0%	64↑3.5%	22↓65.0%
Total Equity	33	40↑22.8%	20↓50.6%	-10↓149.9%	25↑350.9%
Total Debt	43	2↓96.5%	46↑2882.3%	46↑0.9%	2↓96.4%
Net Debt	28	-33↓218.4%	-24↑26.6%	-0↑98.4%	-29↓7211.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-28	-19↑32.4%	-39↓106.8%	-61↓57.9%	-18↑71.1%
Capital Expenditure	-1	-0↑65.8%	-0↓19.9%	-0↑92.5%	0
Free Cash Flow	-28	-19↑33.4%	-39↓105.5%	-61↓56.5%	-18↑71.1%
Stock-Based Comp	6	5↓17.6%	14↑188.4%	7↓50.2%	3↓53.7%
Net Change in Cash	5	19↑265.6%	35↑90.5%	-23↓165.8%	-16↑30.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance